---
schema_version: "secwatch.filing_event.v1"
accession: "0001551306-25-000006"
form_type: "8-K"
ticker: "PGNY"
cik: "0001551306"
company_name: "Progyny, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:16:59.037391+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Progyny expects Q4 2024 revenue, net income, Adjusted EBITDA slightly above prior guidance

## Summary
- Company updates guidance at JPM Healthcare Conference; Q4 results expected slightly above November ranges.
- Previous guidance assumed member activity flat to down vs Q3 2024; improved pacing drove the beat.
- CEO Pete Anevski to present on Jan 14, 2025 at 7:30 a.m. PT; audiocast available on investor site.
- No specific dollar amounts or revised ranges provided in the press release.

## SEC filing metadata
- accession: 0001551306-25-000006
- form_type: 8-K
- ticker: PGNY
- cik: 0001551306
- company_name: Progyny, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/0001551306-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/pgny-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551306-25-000006
- JSON: https://secwatch.observer/filing/0001551306-25-000006.json
- Plain text: https://secwatch.observer/filing/0001551306-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.